Autoimmune mechanisms in type 1 diabetes

Area of Science:

• Immunology
• Endocrinology
• Genetics

Background:

• Type 1 diabetes (T1D) is an immune-mediated disease targeting pancreatic beta-cells.
• Genetic susceptibility and specific HLA haplotypes (DR3-DQ2, DR4-DQ8) are key factors in T1D development.
• Autoimmunity against beta-cell autoantigens, including insulin, GAD, IA-2, and Slc30A8, underlies T1D pathogenesis.

Purpose of the Study:

• To explore the role of T-cells in beta-cell destruction in Type 1 diabetes.
• To investigate the significance of various autoantigens in T1D pathogenesis.
• To evaluate the potential of autoantigen-specific T-cell responses for T1D prediction.

Main Methods:

• Analysis of autoantigen-specific T-cell responses in peripheral blood.
• Identification of key autoantigens involved in T1D.
• Correlation of T-cell responses with disease status and prediction.

Main Results:

• Autoreactive CD4 and CD8 T-cells are implicated in beta-cell destruction.
• Multiple autoantigens (insulin, GAD, IA-2, Slc30A8) are identified in T1D.
• Recent advancements allow clearer discrimination of T1D patients based on T-cell responses.

Conclusions:

• T-cell responses to specific autoantigens are crucial in Type 1 diabetes.
• Autoantibodies and T-cell responses can serve as predictive markers for T1D.
• Understanding T1D autoimmunity is essential for developing targeted therapies.